Perfil
Petra Budde currently works at Oncimmune Holdings Plc, as Chief Scientific Officer from 2023.
Cargos activos de Petra Budde
| Empresas | Cargo | Inicio |
|---|---|---|
| ONCE HLDG | Director Técnico/Científico/I+D | 01/01/2023 |
Oncimmune Germany GmbH
Oncimmune Germany GmbH BiotechnologyHealth Technology Develops antibody and autoantibody biomarker discovery platform | Director Técnico/Científico/I+D | 01/01/2023 |
Antiguos cargos conocidos de Petra Budde.
| Empresas | Cargo | Fin |
|---|---|---|
Protagen AG
Protagen AG BiotechnologyHealth Technology Specializes in the development of novel diagnostic and companion diagnostic tests | Director Técnico/Científico/I+D | 01/01/2019 |
Formación de Petra Budde.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
University of Bielefeld
University of Bielefeld Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protagen AG
Protagen AG BiotechnologyHealth Technology Specializes in the development of novel diagnostic and companion diagnostic tests | Health Technology |
Oncimmune Holdings Plc
Oncimmune Holdings Plc BiotechnologyHealth Technology Provides cancer detection and diagnosis services | Health Technology |
Oncimmune Germany GmbH
Oncimmune Germany GmbH BiotechnologyHealth Technology Develops antibody and autoantibody biomarker discovery platform | Health Technology |
- Bolsa de valores
- Insiders
- Petra Budde
















